Antigua and Barbuda

Reimbursed Care Access

Antigua and Barbuda regulates psychoactive substances under its Misuse of Drugs legislation (principal Misuse of Drugs Act and subsequent amendments). Conventional medical use of ketamine for anesthesia is recognized in practice (and ketamine is on the WHO Model List of Essential Medicines), but most classical psychedelics (psilocybin, MDMA, DMT variants, mescaline, ibogaine, 2C‑series, ayahuasca) are controlled under national scheduling and have no routine reimbursed medical pathway outside authorised research. National law provides for exemptions for medical or scientific purposes when licensed under statutory provisions. [https://sherloc.unodc.org/cld/document/atg/1973/the_misuse_of_drugs_act_1973.html|Antigua & Barbuda Misuse of Drugs Act] [https://extranet.who.int/mindbank/items/6837|Misuse of Drugs (Amendment) Act 2018 – WHO MiNDbank].